HCC in the Setting of Hepatitis B: Key Issues for Clinicians Providing Care for Liver Diseases

Download All
Watch 3 expert faculty in the multimedia module to learn about HCC risk assessment, screening, and surveillance in the setting of hepatitis B. Consolidate your learning with the expert-authored Clinical Focus, faculty ClinicalThought commentaries, and the companion Quick Reference Guide. Share the downloadable slides with your colleagues.
Robert S. Brown, Jr., MD, MPH
Paul Y. Kwo, MD
person default
Yasuhito Tanaka, MD, PhD
Norah Terrault Headshot
Norah Terrault, MD, MPH
Grace LH Wong, 医学博士
Grace LH Wong, MD
Grace LH Wong, MDは

PDF

Download this PDF guide outlining key information on HCC risk assessment, screening, and surveillance in the setting of Hepatitis B infection.

Robert S. Brown, Jr., MD, MPH Released: February 22, 2021

Downloadable Slideset

Gain expert insight on practical approaches to HCC risk assessment, HCC screening and surveillance, and HCC management in the setting of patients with hepatitis B.

Robert S. Brown, Jr., MD, MPH Paul Y. Kwo, MD Norah Terrault Headshot Norah Terrault, MD, MPH Released: March 26, 2021

Video Module

Watch this dynamic panel discussion on HCC risk, screening, surveillance, and management, in the setting of patients with hepatitis B.

Robert S. Brown, Jr., MD, MPH Paul Y. Kwo, MD Norah Terrault Headshot Norah Terrault, MD, MPH Physicians: maximum of 1.25 AMA PRA Category 1 Credits Pharmacists: 1.25 contact hours (0.125 CEUs) Released: March 26, 2021 Expired: March 25, 2022

ClinicalThought

亚太地区在评估 HBV 患者的 HCC 风险和跨学科管理方面的注意事项

Grace LH Wong, 医学博士 Released: April 16, 2021

Asia-Pacific considerations in assessing HCC risk in patients with HBV and interdisciplinary management of HCC.

Grace LH Wong, MD Released: April 15, 2021

Patients achieving a functional cure for chronic hepatitis B with nucleos(t)ide analogue treatment may still develop HCC. What tools do we have to predict which patients will experience progression of liver disease?

person default Yasuhito Tanaka, MD, PhD Released: May 6, 2021

ヌクレオチ(シ)ド類似物治療によって慢性B型肝炎の機能的治癒を達成している患者さんでも、HCCが発生する可能性があります。患者さんが肝臓疾患の進行を経験するかを予測するためには、どのようなツールがあるでしょうか?

person default Yasuhito Tanaka, MD, PhD Released: May 11, 2021

HCC risk scores can inform a personalized approach to HCC surveillance in patients with chronic hepatitis B by allowing patients at very low risk to avoid burdensome surveillance and identifying high-risk patients who may benefit from intensive surveillance

Norah Terrault Headshot Norah Terrault, MD, MPH Released: June 4, 2021

Clinical Focus

Learn from Grace LH Wong, MD, about prevention and treatment of HBV-related HCC in the Asia-Pacific region, where more than 75% of the global population with HBV resides.

Grace LH Wong, MD Released: June 8, 2021

世界のHBV 罹患者の 75% 超が在住する、アジア太平洋地域における HBV-関連の HCC の予防と治療について Grace LH Wong, MDから学ぶ

Grace LH Wong, MDは Released: June 22, 2021

向医学博士 Grace LH Wong 了解亚太地区 HBV 相关 HCC 的预防和治疗,全球 HBV 感染者中有超过 75% 居住在该地区。

Grace LH Wong, MD Released: June 24, 2021

In these slides, expert faculty discusses Asia-Pacific considerations relevant to patients with HCC in the setting of hepatitis B.

Grace LH Wong, MD Released: June 10, 2021

在这些幻灯片中,专家教员讨论了与乙型肝炎环境中的 HCC 患者相关的亚太地区注意事项。

Grace LH Wong, 医学博士 Released: June 18, 2021

これらのスライドでは、専門家教授が、B 型肝炎の状況における  HCC 患者に妥当なアジア太平洋地域の考慮点ついて協議します。

Grace LH Wong, MDは Released: June 18, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue